In PTH-treated rats there was an increase in serum osteocalcin (p < 0.01) and P1NP, and decrease in CTX-II values at the 5-week time point, but at the end of study serum biomarkers in PTH and MM groups were similar. The gene discussed is PTH; the disease is Miyoshi myopathy.